SPL 1.03% 9.8¢ starpharma holdings limited

Ann: Starpharma and Medicxi Partnership Petalion Therapeutics, page-81

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,453 Posts.
    lightbulb Created with Sketch. 822
    I’m afraid you are conveniently missing or ignoring my points. I cannot make them any clearer.

    Starpharma have given away the upside for free. If this program is highly successful in 15 years, then yes the current 22.5 % has potential for significant value. But there is no licence fee and no milestone payments payable to Starpharma.

    Starpharma have taken on the downside risk of failure without any compensation.

    Here’s a maths question for you:
    What is 22.5% of zero?
    Last edited by sarge17: 09/04/24
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.